Metraipolis › archive › dc_16900fd2dde9

Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs — Europe PMC PMID:41155957

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41155957
DOI
10.3390/pharmaceutics17101321
License (as archived)
solo-consultazione
Archived
2026-11-09T09:53:26.445Z
SHA-256 of the archived text
180acaa9435ac81904d2d7ef087841e24030a799fa4e8d7cf7fec04e8aebd127
Stable URL of this page
https://metraipolis.com/documento/dc_16900fd2dde9

How to cite

Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs — Europe PMC PMID:41155957 — Europe PMC (en), https://europepmc.org/article/MED/41155957 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_16900fd2dde9 (Metraipolis archive dc_16900fd2dde9, sha256 180acaa9435ac81904d2d7ef087841e24030a799fa4e8d7cf7fec04e8aebd127)
BibTeX
@misc{dc16900fd2dde9,
  title = {Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs — Europe PMC PMID:41155957},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155957},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_16900fd2dde9; sha256 180acaa9435ac81904d2d7ef087841e24030a799fa4e8d7cf7fec04e8aebd127},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155957. Agents can read the archived copy with the MCP tool read_document.